| |
| |
|
| Insider
Information: |
Lurker Nancy |
| Relationship: |
|
| City: |
Saddle River |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
1,392,856 |
|
|
Indirect Shares
|
232,889 |
|
|
| Direct
Value |
$1,674,881 |
|
|
|
Indirect Value
|
$189,708 |
|
|
| Total
Shares |
1,625,745 |
|
|
| Total
Value |
$1,864,590 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
1.0
|
| Percentage
Gain/Loss : |
 -48.1%
|
 6.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Interpace Biosciences Inc |
IDXG |
CEO, Director |
2015-03-05 |
1,298,998 |
2015-03-05 |
106,000 |
Premium* |
|
|
Mallinckrodt plc |
MNK |
Director |
2016-03-16 |
10,507 |
2013-07-18 |
0 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2024-02-13 |
83,351 |
2024-02-13 |
126,889 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IDXG |
Interpace Biosciences Inc |
CEOOfficer |
• – – |
2008-11-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
140,000 |
|
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2016-03-16 |
4 |
D |
$55.69 |
$25,506 |
D/D |
(458) |
10,507 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
572 |
5,209 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2014-03-20 |
4 |
D |
$69.95 |
$67,921 |
D/D |
(971) |
4,637 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• • – |
2014-11-06 |
4 |
B |
$1.60 |
$1,600 |
I/I |
1,000 |
490,403 |
2.58 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2015-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
1,715 |
6,924 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2014-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
2,574 |
5,608 |
0 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
• • – |
2013-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,034 |
3,034 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• – – |
2009-08-17 |
4 |
B |
$5.05 |
$19,998 |
D/D |
3,960 |
143,960 |
2.74 |
- |
|
| MNK |
Mallinckrodt plc |
Director |
– • – |
2016-03-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,041 |
10,965 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
113,546 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-01-23 |
4 |
S |
$24.97 |
$125,950 |
D/D |
(5,044) |
165,397 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• – – |
2009-08-18 |
4 |
B |
$5.17 |
$31,039 |
D/D |
6,000 |
149,960 |
2.74 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• – – |
2010-12-21 |
4 |
A |
$10.98 |
$99,995 |
D/D |
9,107 |
202,805 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-11-15 |
4 |
AS |
$20.15 |
$201,480 |
D/D |
(10,000) |
103,546 |
0 |
% |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2019-10-12 |
4 |
D |
$2.11 |
$22,618 |
D/D |
(10,745) |
314,455 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• – – |
2011-03-15 |
4 |
OE |
$8.24 |
$94,529 |
D/D |
11,472 |
297,215 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2022-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,466 |
150,281 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,467 |
109,046 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2021-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,717 |
96,579 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2022-02-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,717 |
137,815 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
Executive Vice Chair |
• • – |
2024-02-09 |
4 |
D |
$28.80 |
$430,358 |
D/D |
(14,943) |
158,032 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• • – |
2014-11-10 |
4 |
B |
$1.69 |
$27,090 |
I/I |
16,000 |
533,317 |
2.66 |
- |
|
| IDXG |
Interpace Biosciences Inc |
CEO |
• – – |
2013-03-01 |
4 |
D |
$7.43 |
$120,953 |
D/D |
(16,279) |
331,638 |
0 |
- |
|
| EYPT |
EyePoint Pharmaceuticals ... |
President & CEO |
• • – |
2022-02-09 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,533 |
124,098 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
